BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25940192)

  • 1. Description of leprosy classification at baseline among patients enrolled at the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
    Moura RS; Penna GO; Cardoso LP; de Andrade Pontes MA; Cruz R; de Sá Gonçalves H; Fernandes Penna ML; de Araújo Stefani MM; Bührer-Sékula S
    Am J Trop Med Hyg; 2015 Jun; 92(6):1280-4. PubMed ID: 25940192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
    Hungria EM; Oliveira RM; Penna GO; Aderaldo LC; Pontes MA; Cruz R; Gonçalves HS; Penna ML; Kerr LR; Stefani MM; Bührer-Sékula S
    Infect Dis Poverty; 2016 Dec; 5(1):110. PubMed ID: 27919284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revalidation of various clinical criteria for the classification of leprosy--a clinic-pathological study.
    Gupta R; Kar HK; Bharadwaj M
    Lepr Rev; 2012 Dec; 83(4):354-62. PubMed ID: 23614253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
    Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the ML-Flow test as a tool in classifying and treating leprosy.
    Contin LA; Alves CJ; Fogagnolo L; Nassif PW; Barreto JA; Lauris JR; Nogueira ME
    An Bras Dermatol; 2011; 86(1):91-5. PubMed ID: 21437528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of leprosy reactions in paucibacillary and multibacillary individuals attended at two reference centers in Recife, Pernambuco].
    Teixeira MA; Silveira VM; França ER
    Rev Soc Bras Med Trop; 2010; 43(3):287-92. PubMed ID: 20563498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR).
    Penna GO; Pontes MAA; Talhari S; Gonçalves HS; Talhari C; Pessoa AS; Pedroza V; Bührer-Sékula S; Stefani MMA; Penna MLF
    Braz J Infect Dis; 2024; 28(2):103745. PubMed ID: 38697216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
    Rao PN; Suneetha S; Pratap DV
    Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study to validate various clinical criteria used in classification of leprosy: a study from a tertiary care center in India.
    Thapa M; Sendhil Kumaran M; Narang T; Saikia UN; Sawatkar GU; Dogra S
    Int J Dermatol; 2018 Sep; 57(9):1107-1113. PubMed ID: 29809278
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
    Front Immunol; 2018; 9():915. PubMed ID: 29867930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy beyond MDT: study of follow-up of 100 released from treatment cases.
    Vara N; Agrawal M; Marfatia Y
    Indian J Lepr; 2010; 82(4):189-94. PubMed ID: 21434595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDT-MB therapy in paucibacillary leprosy: a clinicopathological assessment.
    Prasad PV; Babu A; Kaviarasan PK; Viswanathan P; Tippoo R
    Indian J Dermatol Venereol Leprol; 2005; 71(4):242-5. PubMed ID: 16394431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical trial for uniform multidrug therapy for leprosy patients in Brazil: rationale and design.
    Penna GO; Pontes MA; Cruz R; Gonçalves Hde S; Penna ML; Bührer-Sékula S
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():22-7. PubMed ID: 23283449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient profile and treatment satisfaction of Brazilian leprosy patients in a clinical trial of uniform six-month multidrug therapy (U-MDT/CT-BR).
    Ferreira IP; Buhrer-Sékula S; De Oliveira MR; Gonçalves Hde S; Pontes MA; Penna ML; Cruz R; Penna GO
    Lepr Rev; 2014 Dec; 85(4):267-74. PubMed ID: 25675651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996.
    Dasananjali K; Schreuder PA; Pirayavaraporn C
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with anti-phenolic glycolipid-I seropositivity among the household contacts of leprosy cases.
    Carvalho AP; da Conceição Oliveira Coelho Fabri A; Corrêa Oliveira R; Lana FC
    BMC Infect Dis; 2015 May; 15():219. PubMed ID: 26024906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients.
    Bührer-Sékula S; Visschedijk J; Grossi MA; Dhakal KP; Namadi AU; Klatser PR; Oskam L
    Lepr Rev; 2007 Mar; 78(1):70-9. PubMed ID: 17518099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin, or skin and nerve lesions.
    Van Brakel WH; de Soldenhoff R; McDougall AC
    Lepr Rev; 1992 Sep; 63(3):231-46. PubMed ID: 1343818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.
    Cruz RCDS; Bührer-Sékula S; Penna GO; Moraes MEA; Gonçalves HS; Stefani MMA; Penna MLF; Pontes MAA; Talhari S
    An Bras Dermatol; 2018 Jun; 93(3):377-384. PubMed ID: 29924240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.